Related Experiment Video
Updated: Jul 8, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
Hyperthyroidism and severity of orbital disease do not change the central corneal thickness in Graves' ophthalmopathy
1Department of Ophthalmology, Gazi University School of Medicine, Ankara, Turkey. okonuk@gazi.edu.tr
Purpose:
To investigate whether the central corneal thickness (CCT) shows alterations in Graves disease and Graves ophthalmopathy (GO) cases according to the disease severity and hormonal status of the patients.
Methods:
A total of 150 patients (62 male, 88 female) with Graves disease and 32 control subjects (11 male, 21 female) were included in the study. The patients were divided into six groups according to the severity of orbital involvement and thyroid hormone status. Best-corrected visual acuity, pupillary responses, color vision, biomicroscopy, CCT, intraocular pressure, and funduscopy were performed, and proptosis was measured with Hertel exophthalmometry in all patients.
Results:
CCT values of patients with Graves disease and patients with GO with hyperthyroid or euthyroid hormonal status showed no statistical difference among themselves and versus control subjects (p>0.05).
Conclusions:
Hyperthyroidism or severity of orbital disease does not affect the CCT.
Related Concept Videos
Graves' Disease I: Introduction
Graves Disease II: Pathophysiology
Hyperthyroidism II: Pathophysiology
Hyperthyroidism I: Introduction
Hypothyroidism II: Pathophysiology
Glaucoma: Overview